ChemComm
Communication
as the promoiety of nuclease resistant prodrug-type RNA
(REDUCT RNA). Indeed, oligonucleotides containing the
20-O-methyldithiomethyl group were rapidly and efficiently
converted into the corresponding 20-hydroxy oligonucleotides.
The results demonstrated that the REDUCT RNA would be
highly beneficial for in vivo stabilization and activation in cells
for the widespread application of functional RNAs. The second
concept is a novel post-synthetic approach for the synthesis
of oligonucleotides containing the 20-O-methyldithiomethyl
group. To avoid utilization of unstable amidite units containing
the 20-O-alkyldithiomethyl group, the novel post-synthetic
approach was developed. This efficient synthetic method would
make practical applications of oligonucleotides containing the
alkyldithiomethyl group possible. The synthesis of TMBTM-
modified amidite units other than the uridine derivative and the
conversion of TMBTM-modified oligonucleotides consisting of
four natural bases into the 20-O-methyldithiomethyl oligonucleo-
tides are ongoing.
Fig. 2 Kinetics of degradation of oligonucleotides 50-d(TTTTTTTTUMDTMT)-30 18
and 50-d(TTTTTTTTTT)-30 19 with SVPDE.
This work was supported in part by a Grant-in-Aid for Young
Scientists (B), No. 24790121 (to O.N.), from the Ministry of
Education, Culture, Sports, Science and Technology, Japan.
Notes and references
1 N. Sarver, E. M. Cantin, P. S. Chang, J. A. Zaia, P. A. Ladne,
D. A. Stephens and J. J. Rossi, Science, 1990, 247, 1222–1225.
2 C. C. Mello and D. Conte Jr., Nature, 2004, 431, 338–342;
S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber and
T. Tuschl, Nature, 2001, 411, 494–498.
3 L. L. Cummins, S. R. Owens, L. M. Risen, E. A. Lesnik, S. M. Freier,
D. McGee, C. J. Guinosso and P. D. Cook, Nucleic Acids Res., 1995, 23,
2019–2024.
4 Y.-L. Chiu and T. M. Rana, RNA, 2003, 9, 1034–1048.
5 L. Beigelman, A. Karpeisky, J. Matulic-Adamic, P. Haeberli, D. Sweedler
and N. Usman, Nucleic Acids Res., 1995, 23, 4434–4442; L. Beigelman,
J. A. McSwiggen, K. G. Draper, C. Gonzalez, K. Jensen, A. M. Karpeisky,
A. S. Modak, J. Matulic-Adamic, A. B. DiRenzo, P. Haeberli, D. Sweedler,
D. Tracz, S. Grimm, F. E. Wincott, V. G. Thackray and N. Usman, J. Biol.
Chem., 1995, 270, 25702–25708; A. Karpeisky, C. Gonzalez, A. B. Burgin,
N. Usman and L. Beigelman, Nucleosides Nucleotides, 1997, 16, 955–958.
6 S. M. Elbashir, J. Martinez, A. Patkaniowska, W. Lendeckel and
T. Tuschl, EMBO J., 2001, 20, 6877–6888; F. Czauderna, M. Fechtner,
S. Dames, H. Aygu¨n, A. Klippel, G. J. Pronk, K. Giese and
J. Kaufmann, Nucleic Acids Res., 2003, 31, 2705–2716.
Fig. 3 HPLC analysis of the reductive conversion of 15b into 15c by treatment
with 10 mM DTT.
aliquots were removed and analyzed using HPLC. The half-life (t1/2
)
of 19 was less than 20 min, whereas that of 18 was extended to
approximately 40 min (Fig. 2). The result suggests that oligonucleo-
tides bearing the 20-O-methyldithiomethyl group are significantly
more resistant to SVPDE than native DNA. Similar results were also
obtained with 5% fetal bovine serum (Fig. S5, ESI†).
To be activated in the intracellular environment, 20-O-methyl-
dithiomethyl oligonucleotides need to be converted into 20-hydroxy
oligonucleotides under reducing conditions. To assess the
reductive conversion of the 20-O-methyldithiomethyl group into
a 20-hydroxy group, 20-O-methyldithiomethyl oligonucleotide 15b
was treated with 10 mM 1,4-dithiothreitol (DTT) as the reductant
in 100 mM Tris–HCl buffer (pH 8). The redox reaction proceeded
cleanly and efficiently. Deprotection of the promoieties of 15b was
completed within 3 h to afford the corresponding 20-hydroxy
oligonucleotide 15c (Fig. 3). The structure of 15c was confirmed to
be 20-hydroxy oligonucleotide by MALDI-TOF mass analysis (Table S1,
ESI†). Similarly, the other 20-O-methyldithiomethyl oligonucleotides
7 T. Lavergne, C. Baraguey, C. Dupouy, N. Parey, W. Wuensche,
G. Sczakiel, J.-J. Vasseur and F. Debart, J. Org. Chem., 2011, 76,
5719–5731.
8 R. Johnsson, J. G. Lackey, J. J. Bogojeski and M. J. Damha, Bioorg.
Med. Chem. Lett., 2011, 21, 3721–3725.
9 T. Tsujita and H. Okuda, Eur. J. Biochem., 1983, 133, 215–220.
´
10 R. Hong, G. Han, J. M. Fernandez, B. Kim, N. S. Forbes and
V. M. Rotello, J. Am. Chem. Soc., 2006, 128, 1078–1079.
11 M. E. Anderson, Chem.-Biol. Interact., 1998, 112, 1–14.
(14b, 16b, and 17b) were reductively converted into 20-hydroxy 12 D. P. Jones, J. L. Carlson, P. S. Samiec, P. Sternberg Jr., V. C. Mody Jr.,
R. L. Reed and L. A. S. Brown, Clin. Chim. Acta, 1998, 275, 175–184.
oligonucleotides 14c, 16c, and 17c, respectively. Furthermore, the
13 A. Meister and M. E. Anderson, Annu. Rev. Biochem., 1983, 52,
reductive conversion under more physiological conditions (10 mM
711–760.
glutathione, pH 7.0) was conducted. 20-O-methyldithiomethyl 14 A. Semenyuk, A. Foldesi, T. Johansson, C. Estmer-Nilsson,
¨
¨
P. Blomgren, M. Brannvall, L. A. Kirsebom and M. Kwiatkowski,
oligonucleotides 14b and 16b were gradually converted into the
corresponding 20-hydroxy oligonucleotides 14c and 16c (Fig. S3
and S4, ESI†).
Here, we proposed two novel concepts. One is the utilization
of an alkyldithiomethyl group, which is designed to be cleaved
J. Am. Chem. Soc., 2006, 128, 12356–12357.
15 A. Semenyuk and M. Kwiatkowski, Tetrahedron Lett., 2007, 48,
469–472.
16 P. Bishop, C. Jones and J. Chmielewski, Tetrahedron Lett., 1993, 34,
4469–4472.
17 H. Rastogi and D. A. Usher, Nucleic Acids Res., 1995, 23, 4872–4877.
under reducing conditions similar to that in the cytoplasm, 18 S. Vetter, Synth. Commun., 1998, 28, 3219–3223.
c
7622 Chem. Commun., 2013, 49, 7620--7622
This journal is The Royal Society of Chemistry 2013